Wednesday, July 01, 2020 7:18:14 AM
MYOS RENS Up 32% After Hours on Merger and Spin-Out Plan
6:39 pm ET June 30, 2020 (Dow Jones) Print
By Josh Beckerman
MYOS RENS Technology Inc. shares rose 32% to $1.17 after hours as the nutrition products company said it will merge with pharmacy organization MedAvail Inc. and spin out the MYOS muscle health business as a separate company.
MedAvail will pay the spun-out business $2 million in cash upon the closing of the merger and issue a promissory note for an additional $3 million.
MYOS owns Fortetropin, which helps build lean muscle.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
June 30, 2020 18:39 ET (22:39 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM